Yuan Li

6PUBLICATIONS
80CO-AUTHORS
Cancer diagnosisLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 14, 2025
Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with advanced non-small-cell lung cancer in China.

Fei Zhou, Yuan Li, Jian Ming

|Jan 29, 2024
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation.

Zhen Qin, Meiting Yue, Shijie Tang

|Nov 13, 2023
Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial.

Xiaomin Ou, Ruiping Zhai, Wenjun Wei

|Feb 04, 2022
Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non-small cell lung cancer.

Qingyuan Huang, Fei Li, Hai Hu

|Sep 13, 2021
Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets.

Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares

|Nov 16, 2020
Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China.

Qiang Zheng, Yan Huang, Xin Zeng

Pageof 1

Frequent Collaborators

2 joint publications

Kwok-Kin Wong

2 joint publications

Haiquan Chen

1 joint publications

Mercedes L Dalurzo

1 joint publications

Alejandro Avilés-Salas